HALO
#982
Halozyme Therapeutics, Inc. - Common Stock
75.0 5 USD
-0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.39%
Changement Mensuel
+7.03%
Evolution sur 6 mois
+3.08%
Changement Annuel
+12.35%
Clôture Précédente
76.1 1
Open
75.0 5
Low
75.0 5
High
75.0 5
Volume
231
Financials
- Market Capitalization 8.9 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
26.29
ratio cours/chiffre d'affaires
5.97
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 959 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 327.68 USD | +4.17% | +1.30% | +20.96% | +506.93% | 9.14 B USD | ||
| 966 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 54.93 USD | -3.21% | -35.80% | -25.26% | -23.84% | 9.08 B USD | ||
| 988 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.71 USD | +0.05% | +0.19% | +142.08% | +103.67% | 8.83 B USD | ||
| 999 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 98.95 USD | +5.57% | +4.89% | +21.31% | +313.84% | 8.59 B USD |